A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/36 (2006.01) A61K 31/70 (2006.01) A61K 35/12 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) C07K 14/52 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2235685
The invention provides methods and compositions for gene therapy, including antisense therapy. In one embodiment, the compositions comprise hyaluronic acid to promote uptake of nucleic acid by the target cells. The invention is illustrated with reference to treatment of retinal diseases caused by neovascularisation.
Cette invention porte sur des méthodes de thérapie génique ainsi que sur les compositions correspondantes, y compris une thérapie anti-sens. Dans un mode de réalisation, les compositions contiennent de l'acide hyaluronique afin de stimuler l'absorption d'acide nucléique par les cellules cibles. A titre d'exemple, cette invention trouve une application dans le traitement de maladies rétiniennes causées par une néoformation de vaisseaux sanguins.
Constable Ian Jeffrey
Rakoczy Piroska Elizabeth
Hyal Pharmaceutical Australia Limited
Mbm Intellectual Property Law Llp
LandOfFree
Hyaluronic acid as dna carrier for gene therapy and vegf... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hyaluronic acid as dna carrier for gene therapy and vegf..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyaluronic acid as dna carrier for gene therapy and vegf... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1456170